COMPASS Pathways
D

CMPS

9.02500
USD
-0.10
(-1.10%)
بعد الجلسة·8.97000USD-0.05500(-0.61%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
81,346
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
1,278,935,936
أصول ذات صلة

العنوان: COMPASS Pathways Plc

القطاع: الرعاية الصحية
الصناعة: Medical Care Facilities
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

أسئلة شائعة حول سهم COMPASS Pathways